Transmembrane domain I contributes to the permeation pathway for serotonin and ions in the serotonin transporter

Journal of Neuroscience

Volumn 19, Issue 12, 1999, Pages 4705-4717

  Barker, Eric L ^a,b   Moore, Kimberly R ^a   Rakhshan, Fariborz ^a,b   Blakely, Randy D ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Biological transport; Carrier proteins; Molecular structure; Monoamine; Permeation channel; Selectivity filter; Serotonin; Transporter

Indexed keywords

ASPARTIC ACID; BENZYLAMINE DERIVATIVE; CHLORIDE ION; CITALOPRAM; COCAINE; GLUTAMIC ACID; GRAMINE; IMIPRAMINE; MAZINDOL; MUTANT PROTEIN; PAROXETINE; SEROTONIN; SEROTONIN TRANSPORTER; SODIUM ION;

ACIDITY; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CHLORIDE TRANSPORT; CONTROLLED STUDY; ELECTROPHYSIOLOGY; HUMAN; HUMAN CELL; ION CURRENT; MOLECULAR DYNAMICS; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; RECEPTOR OCCUPANCY; SEROTONIN UPTAKE; SODIUM TRANSPORT; STRUCTURE ACTIVITY RELATION; TRANSPORT KINETICS;

EID: 0033564765     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.19-12-04705.1999     Document Type: Article

References (53)

1. Akabas MH, Stauffer DA, Xu M, Karlin A (1992) Acetylcholine receptor channel structure probed in cysteine-substitution mutants. Science 258:307-310.
2. Barker EL, Blakely RD (1995) Norepinephrine and serotonin transporters: molecular targets for antidepressant drugs. In: Psychopharmacology: the fourth generation of progress (Bloom F, Kupfer D, eds) pp 321-333. New York: Raven.
3. Barker EL, Blakely RD (1996) Identification of a single amino acid, phenylalanine 586, that is responsible for high-affinity interactions of tricyclic antidepressants with the human serotonin transporter. Mol Pharmacol 50:957-965.
4. Barker EL, Kimmel HL, Blakely RD (1994) Chimeric human and rat serotonin transporters reveal domains involved in recognition of transporter ligands. Mol Pharmacol 46:799-807.
5. Barker EL, Perlman MA, Adkins EM, Houlihan WJ, Pristupa ZB, Niznik HB, Blakely RD (1998) High affinity recognition of serotonin transporter antagonists defined by species-scanning mutagenesis: an aromatic residue in transmembrane domain I dictates species-selective recognition of citalopram and mazindol. J Biol Chem 273:19459-19468.
6. -)-coupled gamma-aminobutyric acid transporter from rat brain. J Biol Chem 272:1203-1210.
7. Blakely RD, Berson HE, Fremeau Jr RT, Caron MG, Peek MM, Prince HK, Bradley CC (1991a) Cloning and expression of a functional serotonin transporter from rat brain. Nature 354:66-70.
8. Blakely RD, Clark JA, Rudnick G, Amara SG (1991b) Vaccinia-T7 RNA polymerase expression system: evaluation for the expression cloning of plasma membrane transporters. Anal Biochem 194:302-308.
9. Boja JW, Mitchell WM, Patel A, Kopajtic TA, Carroll FI, Lewin AH, Abraham P, Kuhar MJ (1992) High-affinity binding of RTI-55 to dopamine and serotonin transporters in rat brain. Synapse 12:27-36.
10. Buck KJ, Amara SG (1994) Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium. Proc Natl Acad Sci USA 91:12584-12588.
11. + permeation and pH regulation at a mammalian serotonin transporter. J Neurosci.17:2257-2266.
12. Cao YW, Li MY, Mager S, Lester HA (1998) Amino acid residues that control pH modulation of transport-associated current in mammalian serotonin transporters. J Neurosci 18:7739-7749.
13. Chen JG, Liu-Chen S, Rudnick G (1997a) External cysteine residues in the serotonin transporter. Biochemistry 36:1479-1486.
14. Chen JG, Sachpatzidis A, Rudnick G (1997b) The third transmembrane domain of the serotonin transporter contains residues associated with substrate and cocaine binding. J Biol Chem 272:28321-28327.
15. Chen JG, Liu-Chen S, Rudnick G (1998) Determination of external loop topology in the serotonin transporter by site-directed chemical labeling. J Biol Chem 273:12675-12681.
16. Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant and the concentration of inhibitor that causes 50 percent inhibition of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
17. Clark JA (1997) Analysis of the transmembrane topology and membrane assembly of the GAT-1 gamma-aminobutyric acid transporter. J Biol Chem 272:14695-14704.
18. Ferrer JV, Javitch JA (1998) Cocaine alters the accessibility of endogenous cysteines in putative extracellular and intracellular loops of the human dopamine transporter. Proc Natl Acad Sci USA 95:9238-9243.
19. Fuerst TR, Niles E, Studier FW, Moss B (1986) Eukaryotic transient expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci USA 83:8122-8126.
20. Galli A, DeFelice LJ, Duke BJ, Moore KR, Blakely RD (1995) Sodium-dependent norepinephrine-induced currents in norepinephrine-transporter-transfected HEK-293 cells blocked by cocaine and antidepressants. J Exp Biol 198:2197-2212.
21. Galli A, Blakely RD, DeFelice LJ (1996) Norepinephrine transporters have channel modes of conduction. Proc Natl Acad Sci USA 93: 8671-8676.
22. Galli A, Petersen CI, deBlaquiere M, Blakely RD, DeFelice LJ (1997) Drosophila serotonin transporters have voltage-dependent uptake coupled to a serotonin-gated ion channel. J Neurosci 17:3401-3411.
23. Graham D, Esnaud H, Habert E, Langer SZ (1989) A common binding site for tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors at the substrate recognition site of the neuronal sodium-dependent 5-hydroxytryptamine transporter. Biochem Pharmacol 38:3819-3826.
24. Gu H, Wall SC, Rudnick G (1994) Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence. J Biol Chem 269:7124-7130.
25. Humphreys CJ, Wall SC, Rudnick G (1994) Ligand binding to the serotonin transporter: equilibria, kinetics, and ion dependence. Biochemistry 33:9118-9125.
26. Kitayama S, Shimada S, Xu H, Markham L, Donovan DM, Uhl GR (1992) Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding. Proc Natl Acad Sci USA 89:7782-7785.
27. Kunkel TA, Roberts JD, Zakour RA (1987) Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol 154:367-382.
28. Lester HA, Cao YW, Mager S (1996) Listening to neurotransmitter transporters. Neuron 17:807-810.
29. Lin F, Lester HA, Mager S (1996) Single-channel currents produced by the serotonin transporter and analysis of a mutation affecting ion permeation. Biophys J 71:3126-3135.
30. Mager S, Min C, Henry DJ, Chavkin C, Hoffman BJ, Davidson N, Lester HA (1994) Conducting states of a mammalian serotonin transporter. Neuron 12:845-859.
31. Mager S, Kleinberger-Doron N, Keshet GI, Davidson N, Kanner BI, Lester HA (1996) Ion binding and permeation at the GABA transporter GAT1. J Neurosci 16:5405-5414.
32. Melikian HE, McDonald JK, Gu H, Rudnick G, Moore KR, Blakely RD (1994) Human norepinephrine transporter. Biosynthetic studies using a site-directed polyclonal antibody. J Biol Chem 269:12290-12297.
33. Melikian HE, Ramamoorthy S, Tate CG, Blakely RD (1996) Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition. Mol Pharmacol 50:266-276.
34. - neurotransmitter transporters. J Neurochem 71:1785-1803.
35. Pacholczyk T, Blakely RD, Amara SG (1991) Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 350:350-354.
36. Plenge P, Mellerup ET, Honore T, Honore PL (1987) The activity of 25 paroxetine/femoxetine structure variants in various reactions, assumed to be important for the effect of antidepressants. J Pharm Pharmacol 39:877-882.
37. 3H]citalopram binding to the 5HT transporter from brain and platelets. Eur J Pharmacol 206:243-250.
38. Qian Y, Melikian HE, Rye DB, Levey AI, Blakely RD (1995) Identification and characterization of antidepressant-sensitive serotonin transporter proteins. J Neurosci 15:1261-1274.
39. Qian Y, Galli A, Ramamoorthy S, Risso S, DeFelice LJ, Blakely RD (1997) Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression. J Neurosci 17:45-57.
40. Ramamoorthy S, Melikian HE, Qian Y, Blakely RD (1998) Biosynthesis, N-glycosylation, and surface trafficking of biogenic amine transporter proteins. In: Methods in enzymology: neurotransmitter transporters (Amara SG, ed), pp 347-370. San Diego: Academic.
41. Rudnick G (1998a) Bioenergetics of neurotransmitter transport. J Bioenerg Biomembr 30:173-185.
42. Rudnick G (1998b) Ion-coupled neurotransmitter transport: thermodynamic vs. kinetic determinations of stoichiometry. In: Methods in enzymology: neurotransmitter transporters (Amara SG, ed), pp 233-247. San Diego: Academic.
43. Rudnick G, Clark J (1993) From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters. Biochim Biophys Acta 1144:249-263.
44. Rudnick G, Wall SC (1992) The molecular mechanism of "ecstasy": serotonin transporters are targets for MDMA-induced serotonin release. Proc Natl Acad Sci USA 89:1817-1821.
45. Rudnick G, Talvenheimo J, Fishkes H, Nelson PJ (1983) Sodium ion requirements for serotonin transport and imipramine binding. Psychopharmacol Bull 19:545-549.
46. Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463-5467.
47. Sonders MS, Zhu SJ, Zahniser NR, Kavanaugh MP, Amara SG (1997) Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants. J Neurosci 17:960-974.
48. Stauffer DA, Karlin A (1994) Electrostatic potential of the acetylcholine binding sites in the nicotinic receptor probed by reactions of binding-site cysteines with charged methanethiosulfonates. Biochemistry 33:6840-6849.
49. Strader CD, Sigal IS, Dixon RA (1989) Structural basis of beta-adrenergic receptor function. FASEB J 3:1825-1832.
50. Strader CD, Gaffney T, Sugg EE, Candelore MR, Keys R, Patchett AA, Dixon RA (1991) Allele-specific activation of genetically engineered receptors. J Biol Chem 266:5-8.
51. Tatsumi M, Groshan K, Blakely RD, Richelson E (1997) Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 340:249-258.
52. 125I]iodophenyl)tropane binding. Mol Pharmacol 43:264-270.
53. White FJ (1998) Drug addiction: cocaine and the serotonin saga. Nature 393:118-119.